Novo Nordisks started about two years ago as an experiment. Lets bring together an RD team thats interdisciplinary scientists with disease priorities scientists who understand molecules in a very broad sense. We sought to bring a team with very deep cardiometabolic expertise into Cambridge and the wider Boston innovation ecosystem with the anticipation wed come together with entrepreneurs emerging and more established biotechs academia and venture capital